At this point we don't know whether we are being screwed or whether someone is salvaging something out of nothing...
Mgmt as usual has terrible communication w/ shareholders...
$8 mil plus $95 mil plus prob $60 to $80 mil to continue development...
So some entity is willing to spend roughly $180 mil to advance the ball...
A newly formed venture backed by?
Is SK involved? If so how...
Is VC behind it... does BP participate via investment vehicle?
Did JW help put deal together?
Is BP involved in some way?
Who are the folks bringing the IP forward... hopefully better qualified than the SK clown crew... access to patients etc ...will they be running this out of Harvard?
If one reads FierceBiotech on a regular basis, hand me down drugs get low up front payments and are usually back loaded so the terms do not surprise me...
And lots of drugs that BP acquired w/ small biotech company purchases are thrown out after further testing...
There is a lot we don't know and mgmt should be forthcoming in the answers and we need to press them on providing answers.
News 
Market Data 
Discover 
